Immuneoncia Therapeutics is based in Yongin-si, South Korea. It has raised $86M in total funding. Latest round: IPO.
Immuneoncia Therapeutics funding overview
Immuneoncia Therapeutics is based in Yongin-si, South Korea. Immuneoncia Therapeutics has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO announced in May 2025. The round record for Immuneoncia Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Yuhan Corporation, Premier Partners, Paratus Investment. 3 distinct backers are named across the disclosed rounds.
Immuneoncia Therapeutics at a glance
Total raised
$86M
Latest round
IPO
Latest round date
May 2025
Headquarters
Yongin-si, South Korea
Notable investors
Yuhan Corporation, Premier Partners, Paratus Investment
Frequently asked about Immuneoncia Therapeutics funding
How much has Immuneoncia Therapeutics raised?
Immuneoncia Therapeutics has raised $86M in total disclosed funding across the rounds on record.
Who has invested in Immuneoncia Therapeutics?
Yuhan Corporation, Premier Partners, Paratus Investment are named among the investors backing Immuneoncia Therapeutics.
What was the latest Immuneoncia Therapeutics funding round?
The most recent disclosed round is an IPO, announced in May 2025.
Where is Immuneoncia Therapeutics based?
Immuneoncia Therapeutics is based in Yongin-si, South Korea.
When did Immuneoncia Therapeutics last raise?
The last disclosed Immuneoncia Therapeutics round closed in May 2025 at IPO.
We update the Immuneoncia Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Yongin-si and their backers are listed below.
Companies related to Immuneoncia Therapeutics (32)
